Is RUNBEN BIOTECHNOLOGY stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, RUNBEN BIOTECHNOLOGY pays dividends. Last time was Wednesday 29th of May 2024 where the investors holding the stock on Wednesday 29th of May 2024 were paid CNY0.17 per share. Over the last 1 times between 2024 and 2024, RUNBEN BIOTECHNOLOGY has paid CNY0.17 with an average of CNY0.17 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for RUNBEN BIOTECHNOLOGY 10 years ago, but if you had invested on Friday 13th of October 2023 when the price was CNY17.38, you would have made a profit of CNY0.210 per share or 1.21%
Yes, the average daily trading liquidity for RUNBEN BIOTECHNOLOGY is CNY1.94 million. You should therefore be able to get in and out of your positions relatively fast.
RUNBEN BIOTECHNOLOGY has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 10.20, the company's ability to pay off the debt is good. RUNBEN BIOTECHNOLOGY has a very good net profit margin of 22.93% and should have very high tolerances against inflation.
We have calculated the inflation risk for RUNBEN BIOTECHNOLOGY to be low [0 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.